CLASS II Drug recall · Reported 19 Jun 2019 · FDA Enforcement Report

Heparin Sodium 25,000 USP units recalled by B. Braun Medical

B. Braun Medical is recalling Heparin Sodium 25,000 USP units per (100 USP units per mL) in 5% Dextrose Injection Excel, distributed nationwide in the US. The recall was initiated on 13 Jun 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: J7B259, Exp 31 Aug 2019
NDC0264-9567, 0264-9577, 0264-9587
Quantity recalled40,176 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1343-2019
FDA event ID
83089
Recalling firm
B. Braun Medical, Irvine, CA
Manufacturer
B. Braun Medical Inc.
Classification
Class II
Status
Terminated
Recall initiated
13 Jun 2019
FDA classified
13 Jun 2019
Reported
19 Jun 2019
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay
Drug class
Blood Thinners

Timeline

13 Jun 2019Recall initiated by company
13 Jun 2019Classified by FDA+0 days
19 Jun 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCEL Container bag, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018-3524 USA, API from SPAIN, NDC 0264-9587-20.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Is Heparin Sodium 25,000 USP units per (100 USP units per mL) in 5% Dextrose Injection Excel recalled?

Yes. B. Braun Medical recalled Heparin Sodium 25,000 USP units per (100 USP units per mL) in 5% Dextrose Injection Excel on 13 Jun 2019. The recall is Class II and its status is Terminated. Recall number D-1343-2019.

Why was it recalled?

Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.

Which lots are affected?

Lot #: J7B259, Exp 31 Aug 2019

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from B. Braun Medical

All 447

Other Heparin Sodium recalls

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIHeparin Sodium, 25,000 USP units recalled by B. Braun MedicalHeparin Sodium In DextroseB. Braun MedicalPotency & AssayNationwide
DrugCLASS IIHeparin Sodium, 25,000USP units recalled by B. Braun MedicalHeparin Sodium In DextroseB. Braun MedicalPotency & AssayNationwide